Journal article
The Efficacy and Safety of Bisphosphonate Therapy for Osteopenia/Osteoporosis in Patients With Chronic Kidney Disease: A Systematic Review and Individual Patient-Level Meta-Analysis of Placebo-Controlled Randomized Trials
Abstract
Background: The efficacy and safety of bisphosphonate therapy for the treatment of osteoporosis and osteopenia in the setting of chronic kidney disease (CKD) is unclear.
Objective: To determine the effect of bisphosphonate therapy on fractures, bone mineral density (BMD), and adverse events in adults across the spectrum of CKD and dialysis.
Authors
Whitlock R; MacDonald K; Tangri N; Walsh M; Collister D
Journal
Canadian Journal of Kidney Health and Disease, Vol. 11, ,
Publisher
SAGE Publications
Publication Date
1 2024
DOI
10.1177/20543581241283523
ISSN
2054-3581